UPS invests to enhance logistics capabilities to support clinical trials

UPS invests to enhance logistics capabilities to support clinical trials

July 18, 2016: UPS helps pharmaceutical companies and clinical investigators move sensitive materials and specimens globally, particularly in and out of complex geographies by investing in the enhancement of range of specialised solutions.

Enhancements include: development of an easy-to-use shipping system for clinical investigator sites; an expansion of the healthcare control tower network, package intercept and re-icing capabilities; and upgraded operations to move temperature-sensitive biological specimens in and out of more than 60 countries more efficiently.

The new enhancements along with an established network of local specialty couriers will help UPS serve the clinical trial research community by providing efficiency in the transport of specimens without sacrificing service.

UPS serves this expanding market, with capabilities that cover many geographies, from San Francisco to Sao Paulo, or Bangkok to Berlin.

“As innovation in the biopharma industry evolves and with the emergence of personalised therapies and growing direct-to-patient trends, research and development activity will only increase around the world. Our cost-effective portfolio streamlines logistics for clinical trials into one global network across sometimes remote, hard-to-reach locations,” said Habib N’Konou, UPS senior operations director for clinical trials.

“With drug research taking years at a cost in the billions, a product loss or damage, including falling out of temperature range, could mean a costly setback. Our recent improvements to our network will reduce product loss or damage.”

“Improved health outcomes through sophisticated drugs and vaccines starts with successful clinical trials,” said Geoff Light, UPS vice president of global healthcare strategy.

“Optimised logistics is an integral component of medical research and development, and our goal is to help clinical investigators reach any part of the world with maximum efficiency. We will continue to invest in the right global solutions with the aim of becoming the preeminent leader in biological specimen transportation.”

Related Posts:-